July 14, 2022
Bristol-Myers Squibb Co. has decided to quietly dismiss its lawsuit seeking to enforce an arbitral award it won in a fight with Novartis Pharma AG over transgenic mice rather than be forced to place the award on the public docket.
June 15, 2022
A New York federal judge said she won't seal an arbitration panel's decision siding with Bristol-Myers in Novartis' fight against paying royalties for the use of patented test mice, finding that confidentiality went out the window once the public court was asked to enforce the award.
May 23, 2022
Bristol-Myers Squibb is asking a New York court to enforce an award it won in a dispute with Swiss pharmaceutical company Novartis Pharma AG over royalties owed for its use of patented "transgenic" mice to develop therapeutic drugs.